SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950133-01-001208
Filing Date
2001-04-09
Accepted
2001-04-09 00:00:00
Documents
7
Period of Report
2001-05-15

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT w47018ddef14a.htm DEF 14A 218653
2 w47018dpi5-178.gif GRAPHIC 1265
3 w47018dpi5-110.gif GRAPHIC 1217
4 w47018dguiphal1.gif GRAPHIC 7512
5 w47018dcrsmith1.gif GRAPHIC 5230
6 w47018dtcseohs1.gif GRAPHIC 4078
7 w47018dw4701801.gif GRAPHIC 14262
  Complete submission text file 0000950133-01-001208.txt   254131
Mailing Address
Business Address 6611 TRIBUTARY ST BALTIMORE MD 21224 4106316300
GUILFORD PHARMACEUTICALS INC (Filer) CIK: 0000918066 (see all company filings)

IRS No.: 521841960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23736 | Film No.: 1597764
SIC: 2834 Pharmaceutical Preparations